Vesnarinone
![]() | |
Systematic (IUPAC) name | |
---|---|
6-[4-(3,4-dimethoxybenzoyl)piperazin-1-yl]-3,4-dihydro-1H-quinolin-2-one | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number |
81840-15-5 ![]() |
ATC code | none |
PubChem | CID 5663 |
ChemSpider |
5461 ![]() |
UNII |
5COW40EV8M ![]() |
ChEMBL |
CHEMBL17423 ![]() |
Chemical data | |
Formula | C22H25N3O4 |
Molar mass | 395.45 g/mol |
| |
| |
![]() ![]() |
Vesnarinone (INN) is a cardiotonic agent. A mixed phosphodiesterase 3 inhibitor and ion-channel modifier that has modest, dose-dependent, positive inotropic activity, but minimal negative chronotropic activity. Vesnarinone improves ventricular performance most in patients with the worst degree of heart failure.
|
|
This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.